Zydus Lifesciences' Ahmedabad unit get 2 observations in USFDA inspection; stock under pressure

30 Sep 2022 , 09:15 AM

Zydus Lifesciences Limited informed that the USFDA conducted an inspection at the manufacturing facility Zydus Animal Health and Investments Limited, located at SEZ, Ahmedabad. The inspection was conducted between September 23 to September 29, 2022.

This is a new specialised animal health manufacturing plant that will serve the US and other regulated markets.

The inspection was a Pre-Approval Inspection (PAI), which resulted in two observations. None of these observations had anything to do with data integrity. The corporation will address the observations in a timely manner in collaboration with the regulators, said Zydus in its regulatory filing.

At around 9.17 AM, Zydus Lifesciences was trading at Rs382.50 down by 0.27% from its previous closing of Rs383.55 on the BSE.

For feedback and suggestions, write to us at [e-mail]